Mendonça, Leonardo Oliveira 
; Toledo-Barros, M. A. M.; Franco, P. A.; Giavina-Bianchi Júnior, Pedro Francisco ; Kalil Filho, Jorge Elias ; Morato Castro, F. F.; Caroli, Francesco ; Grossi, Alice ; Ceccherini, Isabella ; Robazzi, Tereza Cristina Martins Vicente ; Pileggi, Gelsimara Salviato ; Rivitti-Machado, Maria Cecília ; Sanches Junior, José Antonio ; Gattorno, Marco ; Pontillo, Alessandra
Source: Allergy. Supplement. Conference titles: European Academy of Allergy and Clinical Immunology [EAACI] - [Digital Congress]. Unidades: FM, ICB
Subjects: IMUNOLOGIA, HIPERSENSIBILIDADE, IMUNOGENÉTICA, ELISA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDONÇA, Leonardo Oliveira et al. In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy. Allergy. Supplement. Chichester: Wiley-Blackwell Publishing Ltd. Disponível em: https://doi-org.ez67.periodicos.capes.gov.br/10.1111/all.14508. Acesso em: 20 jul. 2024. , 2020APA
Mendonça, L. O., Toledo-Barros, M. A. M., Franco, P. A., Giavina-Bianchi Júnior, P. F., Kalil Filho, J. E., Morato Castro, F. F., et al. (2020). In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy. Allergy. Supplement. Chichester: Wiley-Blackwell Publishing Ltd. doi:10.1111/all.14508NLM
Mendonça LO, Toledo-Barros MAM, Franco PA, Giavina-Bianchi Júnior PF, Kalil Filho JE, Morato Castro FF, Caroli F, Grossi A, Ceccherini I, Robazzi TCMV, Pileggi GS, Rivitti-Machado MC, Sanches Junior JA, Gattorno M, Pontillo A. In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy [Internet]. Allergy. Supplement. 2020 ; 75 427-428.[citado 2024 jul. 20 ] Available from: https://doi-org.ez67.periodicos.capes.gov.br/10.1111/all.14508Vancouver
Mendonça LO, Toledo-Barros MAM, Franco PA, Giavina-Bianchi Júnior PF, Kalil Filho JE, Morato Castro FF, Caroli F, Grossi A, Ceccherini I, Robazzi TCMV, Pileggi GS, Rivitti-Machado MC, Sanches Junior JA, Gattorno M, Pontillo A. In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy [Internet]. Allergy. Supplement. 2020 ; 75 427-428.[citado 2024 jul. 20 ] Available from: https://doi-org.ez67.periodicos.capes.gov.br/10.1111/all.14508
